Factors | Overall n = 70 | Surviving children n = 50 | Deceased children n = 20 | P-valuea |
---|---|---|---|---|
Female sex, n/n total (%) | 41/70 (58.6) | 31/50 (62.0) | 10/20 (50.0) | 0.36 |
Male sex, n/n total (%) | 29/70 (41.4) | 19/50 (38.0) | 10/20 (50.0) | Â |
Age in months, mean (± SD) | 45.0 (± 12.1) | 44.7 (± 12.1) | 45.8 (± 12.3) | 0.81 |
Ethnic group, n/n total (%) | Â | Â | Â | Â |
 Adja | 7/68 (10.3) | 6/49 (12.2) | 1/19 (5.3) | 0.39 |
 Aizo | 8/68 (11.8) | 8/49 (16.3) | 0 | 0.06 |
 Dendi | 1/68 (1.5) | 0 | 1/19 (5.3) | 0.10 |
 Fon | 34/68 (50.0) | 21/49 (42.9) | 13/19 (68.4) | 0.06 |
 Goun | 4/68 (5.9) | 3/49 (6.1) | 1/19 (5.3) | 0.89 |
 Weme | 1/68 (1.5) | 1/49 (2.0) | 0 | 0.53 |
 Xwla | 2/68 (2.9) | 1/49 (2.0) | 1/19 (5.3) | 0.48 |
 Yoruba | 2/68 (2.9) | 2/49 (4.1) | 0 | 0.37 |
 Other | 9/68 (13.2) | 7/49 (14.3) | 2/19 (10.5) | 0.68 |
Undernet use, n/n total (%) | 62/69 (89.9) | 44/49 (89.8) | 18/20 (90.0) | 0.98 |
Antibiotics use, n/n total (%) | 20/70 (28.6) | 18/50 (36.0) | 2/20 (10.0) | 0.02 |
No measle vaccination, n/n total (%) | 14/67 (20.9) | 9/48 (18.7) | 5/19 (26.3) | 0.49 |
No yellow fever vaccination, n/n total (%) | 18/67 (26.9) | 11/48 (22.9) | 7/19 (36.8) | 0.25 |
Weight in kg, mean (± SD) | 12.6 (± 2.4) | 12.6 (± 2.5) | 12.5 (± 2.4) | 0.86 |
°C axillary temperature, mean (± SD) | 38.3 (± 1.1) | 38.4 (± 1.1) | 38.0 (± 1.0) | 0.21 |
Pulse /min, mean (± SD) | 150.6 (± 21.0) | 151.6 (± 20.6) | 148.1 (± 22.6) | 0.46 |
Blantyre score, mean (± SD) | 1.7 (± 0.5) | 1.8 (± 0.4) | 1.4 (± 0.6) | 0.03 |
Abnormal eyes fund, n/n total (%) | 36/55 (65.5) | 33/50 (66.0) | 3/5 (60.0) | 0.79 |
Hepatomegaly, n/n total (%) | 37/70 (52.9) | 26/50 (52.0) | 11/20 (55.0) | 0.82 |
Splenomegaly, n/n total (%) | 25/70 (35.7) | 14/50 (28.0) | 11/20 (55.0) | 0.03 |
Jaundiceb, n/n total (%) | 33/69 (47.9) | 18/49 (36.7) | 15/20 (75.0) | 0.004 |
Hyperlactatemiac, n/n total (%) | 42/70 (60.0) | 25/50 (50.0) | 17/20 (85.0) | 0.007 |